SCHEMBL2486141

SCHEMBL2486141

CC(C)(C)C(=O)N1CCC[C@H]1C(=O)Nc1nc(-c2ccccc2)c(-c2ccccc2)o1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 7/20 0.52
KDM4E B2RXH2 6/20 0.52
ALDH1A1 P00352 6/20 0.52
NR4A2 P43354 1/20 0.52
KMT2A Q03164 3/20 0.47
TDP1 Q9NUW8 5/20 0.47
HTT P42858 4/20 0.47
HPGD P15428 4/20 0.47
MEN1 O00255 2/20 0.46
SMN1; SMN2 Q16637 5/20 0.44
CYP1A2 P05177 1/20 0.44
POLB P06746 1/20 0.44
HSP90AA1 P07900 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
CCR6 P51684 1/20 0.44
RIPK1 Q13546 1/20 0.44
MAPT P10636 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2485805 0.87 USP30 (0.54) LMNAKDM4EALDH1A1NR4A2KMT2A
SCHEMBL2485807 0.87 USP30 (0.54) LMNAKDM4EALDH1A1NR4A2KMT2A
SCHEMBL2486771 0.76 ADORA3 (0.57) LMNAALDH1A1KMT2ATDP1HTT
SCHEMBL2317426 0.75 HCRTR2 (0.48) LMNARIPK1CNR2HCRTR2
SCHEMBL2320681 0.75 HCRTR2 (0.48) LMNARIPK1CNR2HCRTR2
SCHEMBL2488297 0.72 ADORA3 (0.49) LMNAALDH1A1POLBCNR2USP30
SCHEMBL13571486 0.71 ALDH1A1 (0.45) LMNAALDH1A1HTTPOLBCYP2C9
SCHEMBL28471497 0.70 CYP2C9 (0.54) LMNAKDM4EALDH1A1HTTSMN1; SMN2
SCHEMBL2176361 0.69 F2 (0.50) LMNAKDM4EALDH1A1HTTPOLB
SCHEMBL12491697 0.69 F2 (0.50) LMNAKDM4EALDH1A1HTTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2548618-A2 Organic compounds Novartis AG (CH) 2013-01-23 EP disclosed
EP-2380631-A1 Heteroaryl derivatives as DGAT1 inhibitors Novartis AG (CH) 2011-10-26 EP disclosed
EP-2380631-A1 Heteroaryl derivatives as DGAT1 inhibitors Novartis AG (CH) 2011-10-26 EP disclosed